MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202617067513 A) filed by Pneuma Respiratory, Inc. on May 29, 2026, for Methods And Devices For The Treatment Of Respiratory Disease.
Inventors include Culpepper, Matthew; and Kesten, Steven.
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: Methods for treating a precancerous lung condition comprise administering droplets ejected from an electronic droplet delivery device directly to a precancerous lesion or dysplasia in a human or animal lung, wherein the droplets include one or more inhalable therapeutic agents selected from the group consisting of a chemotherapeutic drug, immunotherapeutic agent, monoclonal antibody, check point inhibitor, nucleic acid, gene, antisense oligonucleotide, siRNA, shRNA, and combinations thereof.
Disclaimer: Curated by HT Syndication.
